First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Up 275.0% in January

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 1,500 shares, an increase of 275.0% from the December 31st total of 400 shares. Based on an average daily volume of 2,400 shares, the days-to-cover ratio is currently 0.6 days.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

FTXH stock traded up $0.18 during midday trading on Wednesday, reaching $27.79. The company had a trading volume of 191 shares, compared to its average volume of 2,471. The company has a market capitalization of $15.28 million, a price-to-earnings ratio of 15.98 and a beta of 0.70. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $25.73 and a 1-year high of $29.72. The stock has a 50 day moving average price of $27.46 and a 200-day moving average price of $28.24.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently declared a dividend, which was paid on Tuesday, December 31st. Investors of record on Friday, December 13th were given a dividend of $0.1304 per share. This is a positive change from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date was Friday, December 13th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.